Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors
Clinical trial NCT01379287 · COMPLETED
Trial details
- NCT number
- NCT01379287
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-20
- Primary completion
- 2023-01-31
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.